Prevalence and factors associated with hepatic steatosis in HCV-HIV co-infected patients.

被引：0
|
作者：
Castera, L
Neau, D
Winnock, M
Le Bail, B
Geraut, L
Dupon, M
Lacoste, D
Pellegrin, JL
Trouette, H
de Ledinghen, V
Lafon, ME
Bioulac-Sage, P
Dabis, F
机构：
[1] CHU Bordeaux, Serv Hepatogastroenterol, Bordeaux, France
[2] Hop Pellegrin, Serv Malad Infect, F-33076 Bordeaux, France
[3] Univ Bordeaux 2, ISPED, INSERM, U593, F-33076 Bordeaux, France
[4] Hop Pellegrin, Serv Anatomopathol, F-33076 Bordeaux, France
[5] Hop St Andre, Serv Med Interne, Bordeaux, France
[6] Hop Haut Leveque, Serv Med Interne, Pessac, France
[7] Hop Haut Leveque, Serv Anatomopathol, Pessac, France
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：414A / 414A
页数：1
相关论文
共 50 条
  • [1] Prevalence and factors associated with hepatic steatosis in HCV-HIV co-infected patients
    Neau, D
    Winnock, M
    Le Bail, B
    Castéra, L
    Géraut, L
    Dupon, M
    Ragnaud, JM
    Lacoste, D
    Lafon, ME
    Bioulac, P
    Dabis, F
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S100 - S100
  • [2] Histologic findings and clinical characteristic associated with steatosis in HIV/HCV co-infected patients.
    Marks, KM
    Petrovic, LM
    Total, AH
    Murray, MP
    Gulick, RM
    Glesby, MJ
    [J]. HEPATOLOGY, 2004, 40 (04) : 457A - 457A
  • [3] HCV-HIV co-infected patients: no longer a "special' population?
    Sulkowski, Mark S.
    [J]. LIVER INTERNATIONAL, 2016, 36 : 43 - 46
  • [4] Prevalence of risk factors for HCV transmission in HIV infected and HIV/HCV co-infected patients
    Bollepalli, S
    Mahthieson, K
    Post, J
    Hillier, A
    Nadir, A
    [J]. HEPATOLOGY, 2005, 42 (04) : 423A - 423A
  • [5] Survival in HCV/HIV co-infected patients.
    Hassanein, TI
    Aronson, N
    Oliver, DL
    Barber, E
    Hilsabeck, RC
    Chatfield, E
    Stewart, M
    Mathews, C
    [J]. HEPATOLOGY, 2001, 34 (04) : 232A - 232A
  • [6] Regression of Liver Stiffness after Successful HCV-Treatment and Associated Factors in HCV Mono-Infected and HCV-HIV Co-Infected Patients
    Malin, Jakob
    Boesecke, Christoph
    Schware-Zander, Carolynne
    Wasmuth, Jan Christian
    Schlabe, Stefan
    Trebicka, Jonel
    Spengler, Ulrich
    Llibre, Joseph Maria
    Jou, Toni
    Puig, Jordi
    Clotet, Bonaventura
    Rockstroh, Juergen Kurt
    [J]. HEPATOLOGY, 2018, 68 : 421A - 421A
  • [7] Provider-Based Barriers to HCV Treatment in HCV-HIV Co-Infected Patients
    Surace, Lindsey T.
    Wong, Michael
    Baden, Rachel
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S935 - S936
  • [8] Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis
    Pembroke, Thomas
    Deschenes, Marc
    Lebouche, Bertrand
    Benmassaoud, Amine
    Sewitch, Maida
    Ghali, Peter
    Wong, Philip
    Halme, Alex
    Vuille-Lessard, Elise
    Pexos, Costa
    Klein, Marina B.
    Sebastiani, Giada
    [J]. JOURNAL OF HEPATOLOGY, 2017, 67 (04) : 801 - 808
  • [9] Factors associated with liver fibrosis in HIV/HCV co-infected patients
    Bani-Sadr, F
    Perronne, C
    Pol, S
    Rosenthal, E
    Carrat, F
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 126 - 126
  • [10] HCV treatment patterns and utilization for HCV mono-infected and HCV-HIV co-infected patients in the veterans administration
    Tam, HK
    Phippard, AE
    Baran, RW
    Lanza, LL
    Bozzette, SA
    [J]. HEPATOLOGY, 2005, 42 (04) : 653A - 653A
12345